Literature DB >> 31924541

Excitation-contraction coupling and relaxation alteration in right ventricular remodelling caused by pulmonary arterial hypertension.

Fabrice Antigny1, Olaf Mercier2, Marc Humbert2, Jessica Sabourin3.   

Abstract

Pulmonary arterial hypertension is a progressive and lethal cardiopulmonary disease. The rise in right ventricular afterload leads to right ventricular hypertrophy and failure. Right ventricular failure is the most important prognostic factor for morbidity and mortality in pulmonary arterial hypertension or pulmonary hypertension caused by left heart diseases. Surprisingly, the right ventricle is not targeted by pulmonary arterial hypertension-specific therapies. The current profound lack of basic understanding of pulmonary arterial hypertension-related right ventricular remodelling can explain, at least in part, this paradox. The physiology and haemodynamic function of the right ventricle in the normal state differ considerably from those of the left ventricle, and the known mechanisms of left ventricular dysfunction cannot be generalized to right ventricular dysfunction. Ion channel activities and calcium homeostasis tightly regulate cardiac function, and their dysfunction contributes to the pathogenesis of cardiac diseases. This review focuses on the ion channels (potassium, calcium) and intracellular calcium handling remodelling involved in right ventricular hypertrophy and dysfunction caused by pulmonary arterial hypertension.
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Couplage excitation-contraction; Excitation-contraction coupling; HTAP; KCNK3; Orai1; PAH; Right ventricle; TRPC; Ventricule droit

Mesh:

Substances:

Year:  2020        PMID: 31924541     DOI: 10.1016/j.acvd.2019.10.009

Source DB:  PubMed          Journal:  Arch Cardiovasc Dis        ISSN: 1875-2128            Impact factor:   2.340


  7 in total

1.  Diagnostic value of miRNA expression and right ventricular echocardiographic functional parameters for chronic thromboembolic pulmonary hypertension with right ventricular dysfunction and injury.

Authors:  Ran Miao; Juanni Gong; Xiaojuan Guo; Dichen Guo; Xinyuan Zhang; Huimin Hu; Jiuchang Zhong; Yuanhua Yang; Yidan Li
Journal:  BMC Pulm Med       Date:  2022-04-29       Impact factor: 3.320

2.  Right predominant electrical remodeling in a pure model of pulmonary hypertension promotes reentrant arrhythmias.

Authors:  Benjamin Strauss; Malik Bisserier; Emerson Obus; Michael G Katz; Anthony Fargnoli; Marine Cacheux; Joseph G Akar; James P Hummel; Lahouaria Hadri; Yassine Sassi; Fadi G Akar
Journal:  Heart Rhythm       Date:  2021-09-23       Impact factor: 6.779

Review 3.  Implication of Potassium Channels in the Pathophysiology of Pulmonary Arterial Hypertension.

Authors:  Hélène Le Ribeuz; Véronique Capuano; Barbara Girerd; Marc Humbert; David Montani; Fabrice Antigny
Journal:  Biomolecules       Date:  2020-09-01

Review 4.  Exploring Functional Differences between the Right and Left Ventricles to Better Understand Right Ventricular Dysfunction.

Authors:  Judith Bernal-Ramirez; Magda C Díaz-Vesga; Matias Talamilla; Andrea Méndez; Clara Quiroga; Javier A Garza-Cervantes; Anay Lázaro-Alfaro; Carlos Jerjes-Sanchez; Mauricio Henríquez; Gerardo García-Rivas; Zully Pedrozo
Journal:  Oxid Med Cell Longev       Date:  2021-08-28       Impact factor: 6.543

5.  Contractile Behavior of Right Atrial Myocardium of Healthy Rats and Rats with the Experimental Model of Pulmonary Hypertension.

Authors:  Oleg Lookin; Elena Mukhlynina; Yuri Protsenko
Journal:  Int J Mol Sci       Date:  2022-04-10       Impact factor: 6.208

6.  MicroRNA-194 inhibits isoproterenol-induced chronic cardiac hypertrophy via targeting CnA/NFATc2 signaling in H9c2 cells.

Authors:  Jian Wang; Yucheng An; Jun Lin; Gang Tang
Journal:  Ann Transl Med       Date:  2022-07

Review 7.  Role of Store-Operated Ca2+ Entry in the Pulmonary Vascular Remodeling Occurring in Pulmonary Arterial Hypertension.

Authors:  Bastien Masson; David Montani; Marc Humbert; Véronique Capuano; Fabrice Antigny
Journal:  Biomolecules       Date:  2021-11-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.